Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 USD | -0.69% | +5.93% | -22.28% |
Financials (USD)
Sales 2024 * | 65.25M | Sales 2025 * | 79.04M | Capitalization | 140M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -32M | EV / Sales 2024 * | 2.14 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.77 x |
P/E ratio 2024 * |
-3.39
x | P/E ratio 2025 * |
-4.43
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 18.93% |
Latest transcript on Biodesix, Inc.
1 day | -0.69% | ||
1 week | +6.67% | ||
Current month | -6.49% | ||
1 month | -8.86% | ||
3 months | -20.88% | ||
6 months | -6.49% | ||
Current year | -21.74% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 11-02-28 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 08-05-31 |
Jack Schuler
BRD | Director/Board Member | 83 | 11-12-31 |
Jon Kayyem
BRD | Director/Board Member | 60 | 21-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.43 | -0.69% | 19 953 |
24-03-27 | 1.44 | -0.69% | 30,255 |
24-03-26 | 1.45 | +0.69% | 43,583 |
24-03-25 | 1.44 | +4.35% | 104,529 |
24-03-22 | 1.38 | +2.22% | 86,795 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.74% | 140M | |
-8.32% | 9.16B | |
-9.54% | 3.67B | |
+39.46% | 3.57B | |
-11.65% | 2.27B | |
-6.06% | 1.94B | |
-16.08% | 1.66B | |
-25.87% | 1.53B | |
-7.98% | 1.09B | |
+3.02% | 1.06B |